TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,717,000 | -87.7% | 77,915 | -82.8% | 0.01% | -88.9% |
| Q3 2021 | $30,177,000 | -17.3% | 454,268 | -2.8% | 0.07% | -18.2% |
| Q2 2021 | $36,469,000 | -65.1% | 467,422 | -57.7% | 0.09% | -66.9% |
| Q1 2021 | $104,408,000 | -35.0% | 1,103,796 | -16.3% | 0.27% | -37.3% |
| Q4 2020 | $160,635,000 | +117.2% | 1,318,298 | +55.7% | 0.42% | +79.7% |
| Q3 2020 | $73,949,000 | +39.2% | 846,486 | +2.9% | 0.24% | +26.9% |
| Q2 2020 | $53,141,000 | +20.8% | 822,743 | -16.5% | 0.19% | -4.6% |
| Q1 2020 | $43,992,000 | +4.1% | 985,038 | +45.2% | 0.20% | +38.3% |
| Q4 2019 | $42,267,000 | +238.8% | 678,552 | +104.5% | 0.14% | +235.7% |
| Q3 2019 | $12,475,000 | +1.2% | 331,782 | +9.6% | 0.04% | +5.0% |
| Q2 2019 | $12,322,000 | – | 302,746 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |